| |
| |
|
| Insider
Information: |
Bailey John E. (jack) Jr. |
| Relationship: |
|
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
489,594 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,438,178 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
489,594 |
|
|
| Total
Value |
$2,438,178 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
G1 Therapeutics Inc |
GTHX |
|
2024-01-03 |
489,594 |
2020-11-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2024-01-03 |
4 |
S |
$3.12 |
$36,447 |
D/D |
(11,686) |
489,594 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
100,700 |
501,280 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2024-01-02 |
4 |
S |
$3.27 |
$108,006 |
D/D |
(32,983) |
400,580 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2023-07-05 |
4 |
AS |
$2.45 |
$6,672 |
D/D |
(2,719) |
433,563 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
160,000 |
436,282 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2023-01-04 |
4 |
S |
$5.58 |
$31,262 |
D/D |
(5,607) |
276,282 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2023-01-03 |
4 |
S |
$5.85 |
$187,452 |
D/D |
(32,019) |
281,889 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
80,700 |
313,908 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2022-01-03 |
4 |
S |
$10.41 |
$355,262 |
D/D |
(34,125) |
233,208 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
46,000 |
267,333 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
213,333 |
221,333 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-11-11 |
4 |
B |
$12.83 |
$51,320 |
D/D |
4,000 |
8,000 |
0.01 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-11-10 |
4 |
B |
$12.76 |
$51,055 |
D/D |
4,000 |
4,000 |
0.01 |
% |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
